市场调查报告书
商品编码
1290896
成瘾治疗市场:现状分析与预测(2022-2030年)Addiction Treatment Market: Current Analysis and Forecast (2022-2030) |
由于成瘾和药物滥用疾病的患病率不断增加,成瘾治疗市场预计将以 6% 左右的速度稳定增长。此外,医疗技术的进步、新治疗方法的开发、社会对成瘾认识的提高以及减轻与接受治疗相关的负担的努力也有助于市场增长。例如,2022 年 3 月,德克萨斯州卫生与公众服务部发起了一项耗资 2,320 万美元的公众宣传活动,帮助人们获得成瘾治疗和服务,并预防药物滥用疾病。
为了更好地了解成瘾治疗行业的市场采用情况,我们将市场分为北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、意大利、欧洲其他地区)、亚太地区(中国、日本)、印度和亚太地区其他地区)以及世界其他地区的国家(基于其全球影响力)。预计北美在预测期内将以显着的复合年增长率增长。这主要是由于成瘾和药物滥用疾病的患病率不断增加,以及人们越来越意识到有效治疗方案的必要性。该地区拥有完善的医疗保健系统和先进的医疗技术,从而促进了新的创新疗法的发展。此外,政府还采取措施增加该领域的研发资金,进一步促进市场的增长。
Addiction treatment refers to a range of interventions and therapies designed to help individuals overcome addiction and substance abuse disorders. Treatment options may include medical interventions, behavioral therapies, counseling, and support groups. The goal of addiction treatment is to help individuals break free from the cycle of addiction and develop the skills and strategies necessary to maintain long-term recovery. Treatment programs may be tailored to address the specific needs of the individual, taking into account factors such as the severity of the addiction, co-occurring mental health conditions, and personal preferences. Effective addiction treatment typically involves a combination of therapies and support services, as well as ongoing monitoring and follow-up care to support long-term recovery.
The addiction treatment market is expected to grow at a steady rate of around 6% owing to the increasing prevalence of addiction and substance abuse disorders. Moreover, advancements in medical technology and the development of new treatment methods, increased public awareness of addiction, and efforts to reduce the associated with seeking treatment have also contributed to the growth of the market. For instance, Texas Health and Human Services launched a $23.2 million public awareness campaign in March 2022 to help people get access to addiction treatment and services and prevent substance abuse disorders.
Based on treatment type, the market is segmented into alcohol addiction treatment, tobacco treatment, opioid treatment, and others. Among these, the alcohol addiction treatment category is to witness a higher CAGR during the forecast period. This is mainly due to its high consumption and the large number of people addicted to alcohol. For instance, as per CDC, around 17% of the population are binge alcohol drinkers in the U.S., and 6% are exposed to heavy drinking.
On the basis of treatment centers, the market is categorized into inpatient centers, residential centers, rehabilitation centers, and others. Among these, the inpatient centers held a significant share of the market in 2021. This is mainly due to these centers providing a safe and structured environment for individuals to detox from drugs or alcohol under the supervision of medical professionals. This can be crucial for individuals who are physically dependent on a substance, as withdrawal symptoms can be severe and even life-threatening in some cases.
Based on the distribution channel, the addiction treatment market has been classified into hospital pharmacies, medical stores, and others. The hospital pharmacies category is to witness higher adoption of addiction treatment during the forecast period. This is mainly due to the availability of a variety of services & products to help patients overcome addiction. Also, the demand for addiction treatment continues to grow because of hospital pharmacies will be well-positioned to meet the needs of patients and contribute to the growth of this segment.
For a better understanding of the market adoption of the addiction treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the growing prevalence of addiction and substance abuse disorders, along with the rising awareness of the need for effective treatment options. The region has a well-established healthcare system and access to advanced medical technology, which has led to the development of new and innovative treatment methods. Additionally, the government has taken initiatives to increase funding for research and development in the field, further contributing to the market growth.
Some of the major players operating in the market include: Cipla Inc., Alkermes, Pfizer Inc., Orexo AB, GSK plc., Sandoz International GmbH, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, and Indivior PLC